Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyMyelomaTeam Member asked a question 💭
Knoxville, TN
June 2
 · 
Reactions
MyMyelomaTeam

Smoldering multiple myeloma (SMM) is a precancerous condition that sits between a milder condition called MGUS and active multiple myeloma. It involves abnormal plasma cells producing too much M protein, but without causing any noticeable symptoms — which is why it's also called asymptomatic myeloma.

Because there are no Show Full Answer

Smoldering multiple myeloma (SMM) is a precancerous condition that sits between a milder condition called MGUS and active multiple myeloma. It involves abnormal plasma cells producing too much M protein, but without causing any noticeable symptoms — which is why it's also called asymptomatic myeloma.

Because there are no symptoms, SMM is often picked up through routine blood tests rather than because something feels wrong. The chance of SMM progressing to active myeloma decreases over time:

- First 5 years: about 10% chance per year
- Years 5–10: drops to around 3% per year
- After 10 years: roughly 1% per year

Certain factors can increase the risk of progression, including:

- High levels of M protein (or rising M protein over time)
- High numbers of abnormal plasma cells in the bone marrow
- Specific gene changes in plasma cells
- Bone lesions showing up on imaging
- M protein made from IgA rather than IgG For people with SMM, regular monitoring with follow-up visits and blood tests is really important to catch any signs of progression early. For those considered "high-risk" SMM, doctors may recommend starting treatment sooner rather than later.

It's always worth having an open conversation with a healthcare provider about where things stand and what approach makes the most sense for each individual situation.

June 2

Related Questions

View All
A MyMyelomaTeam Member asked a question 💭
Manchester, ME

A MyMyelomaTeam Subscriber asked a question 💭

A MyMyelomaTeam Subscriber asked a question 💭

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In